Related Experiment Video
Updated: Jul 3, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
Lubiprostone: a novel treatment for chronic constipation
Brian E Lacy1, L Campbell Levy
1Section of Gastroenterology & Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA. brian.lacy@hitchcock.org
Lubiprostone, a novel prescription medication, offers a new treatment option for chronic constipation. It works by activating chloride channels to improve intestinal fluid secretion and transit, thereby relieving constipation symptoms.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Chronic constipation is a prevalent condition significantly impacting patient quality of life and healthcare costs.
- While lifestyle changes and over-the-counter options help some, many patients require prescription treatments for persistent symptoms.
- Three FDA-approved prescription medications are available for adult chronic constipation.
Purpose of the Study:
- To review lubiprostone, the newest FDA-approved medication for chronic constipation.
- To provide an overview of chloride channel function in the gastrointestinal tract.
- To detail the structure, function, pharmacokinetics, safety, and efficacy of lubiprostone.
Main Methods:
- Literature review focusing on lubiprostone and gastrointestinal chloride channels.
- Analysis of lubiprostone's mechanism of action as a prostaglandin E1 analogue.
- Discussion of clinical trial data regarding lubiprostone's safety and efficacy.
Main Results:
- Lubiprostone activates specific gastrointestinal chloride channels.
- This activation stimulates intestinal fluid secretion and enhances gastrointestinal transit.
- Lubiprostone has demonstrated safety and efficacy in improving chronic constipation symptoms.
Conclusions:
- Lubiprostone represents a significant advancement in the pharmacological treatment of chronic constipation.
- Understanding chloride channel activation is key to lubiprostone's therapeutic effect.
- This review provides comprehensive information on lubiprostone for clinicians and researchers.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...